Nonfatal Stroke, Cardiac Disease, and Diabetes Mellitus in Hypopituitary Patients on Hormone Replacement Including Growth Hormone
Author(s) -
Helene Holmer,
Johan Svensson,
Lars Rylander,
Gudmundur Johannsson,
Thord Rosén,
BengtÅke Bengtsson,
Marja Thorén,
Charlotte Höybye,
Marie Degerblad,
Margareta Bramnert,
Erik Hägg,
Britt Edén Engström,
Bertil Ekman,
Bo Norrving,
Lars Hagmar,
Eva-Marie Erfurth
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-0458
Subject(s) - medicine , diabetes mellitus , stroke (engine) , population , incidence (geometry) , hormone replacement therapy (female to male) , endocrinology , growth hormone deficiency , context (archaeology) , hypopituitarism , pediatrics , hormone , testosterone (patch) , growth hormone , mechanical engineering , physics , environmental health , optics , engineering , paleontology , biology
The impact of long-term GH replacement on cerebrovascular and cardiovascular diseases and diabetes mellitus in hypopituitary patients is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom